-
Product Insights
Likelihood of Approval Analysis for Anemia in Chronic Kidney Disease (Renal Anemia)
Overview How likely is it that the drugs in Anemia in Chronic Kidney Disease (Renal Anemia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anemia in Chronic Kidney Disease (Renal Anemia)...
-
Sector Analysis
NewResistant Hypertension (RH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Resistant Hypertension (RH) Marketed and Pipeline Drugs Report Overview Resistant Hypertension (RH) refers to high blood pressure (BP) that is above the target level in a patient. This occurs even when they are taking three different classes of antihypertensive medications concurrently. These medication classes typically include diuretics, long-acting calcium channel blockers, and renin-angiotensin system blockers (ACEs or ARBs). The Resistant Hypertension (RH) marketed, and pipeline drugs research report includes an assessment of the disease epidemiology, leading marketed products with sales...
-
Analyst Opinions
NewOil and Gas Sector Strategies in Electric Vehicles
Oil and Gas Sector Strategies in EV Report Overview As the world races to meet net zero targets, both public and private sectors are having to find alternative solutions and invest in innovative technologies. The transportation sector accounts for a significant portion of the global energy use, leading to a hunt for alternative fuel solutions for sustainable mobility. A type of alternative fuel vehicle that has been growing rapidly is battery electric vehicles (BEVs), also referred to as EVs. The...
-
Product Insights
Likelihood of Approval Analysis for Food Allergy
Overview How likely is it that the drugs in Food Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Food Allergy Overview Food allergies are immune system reactions to certain proteins...
-
Product Insights
Likelihood of Approval Analysis for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Overview How likely is it that the drugs in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Overview Adrenoleukodystrophy is a disorder that...
-
Company Insights
NewSilverchain – Digital Transformation Strategies
Silverchain Digital Transformation Strategies Overview Silverchain leverages a real-time, cloud-based Microsoft platform to consolidate real-time patient care information on a single platform. Cloud, virtual care and telemedicine, connected patients, and mixed reality are among the key technologies under focus for the company. The annual ICT spending of Silverchain was estimated at $9.4 million in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and communications from vendors. Silverchain leverages a real-time, cloud-based Microsoft...
-
Product Insights
Micromobility in Insurance – Market Trends and Dynamics, 2024
Reasons to buy the ‘Micromobility in Insurance’ market report: Get a comprehensive overview of the micromobility insurance market. Examine the critical success factors driving the micromobility insurance market to gain a competitive edge. Gain insights on the insurance dynamics in micromobility and the key regulations in major countries. Find out what vehicles are most attributed to micromobility and how are consumers and businesses using these vehicles. How is our ‘Micromobility in Insurance’ report unique from other reports in the market?...
-
Thematic Analysis
NewStrategic Partnerships in Fintech – Thematic Intelligence
Reasons to buy the ‘Strategic Partnerships in Fintech’ thematic intelligence report: Gain access to a scientific overview of strategic fintech partnerships. Analyze studies of emerging technological trends and their broader impact on the market. Identify the key categories of fintech partnership and a few of the major players in each category. Explore the role of digitization of banking and the partnership opportunities it creates across front, middle, and back-office functions. How is our ‘Strategic Partnerships in Fintech’ report unique from...
-
Sector Analysis
Fuchs Endothelial Corneal Dystrophy (FECD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Fuchs Endothelial Corneal Dystrophy Marketed and Pipeline Drugs Report Overview Fuchs Endothelial Corneal Dystrophy (FECD) is a bilateral, slowly progressive, often asymmetric corneal disease. FECD is a sporadic or autosomal dominant dystrophy involving the endothelial layer of the cornea. Key Mechanisms of Action (Pipeline) ·      Enzyme Inhibitor ·      Receptor Agonist ·      Protein and Peptide Inhibitor ·      Transporter Inhibitor Key Molecule Types (Pipeline) ·      Small Molecule ·      Biologic Key Routes of Administration (Pipeline) ·      Topical ·      Oral ·      Injection Top Sponsors...